CIDRAP newsletters options
Neutralizing antibodies were about fourfold higher than with Pfizer's original COVID vaccine.
Muliple respiratory viruses are already straining health systems, with children among the hardest hit groups.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
In a new study in BMC Medicine, Dutch researchers report that, 12 months after illness onset, people with initially moderate to severe COVID-19 still had impaired health-related quality of life (HRQL), but the same was not true for mild COVID-19.
A study of hospitalized COVID-19 patients in Michigan found that procalcitonin (PCT) trends were associated with the decision to initiate antibiotics and duration of treatment, independent of bacterial pneumonia (bPNA) status, researchers reported today in Infection Control & Hospital Epidemiology.
Data show 53% of infections are transmitted 1 to 4 days before symptoms appear.
One report details a massive NYC effort to probe 941,035 COVID-19 cases and follow up with their contacts.
An investigational antibiotic for uncomplicated urinary tract infections met trial goals.
Flu activity is starting to rise in parts of the Northern Hemisphere, including Europe and North America, the World Health Organization (WHO) said in its latest global flu update, which covers data through Oct 16.
COVID-19 vaccination of children in Qatar was tied to low to modest, rapidly waning protection against infection with the Omicron variant, but teens had slightly more robust, longer-lasting immunity, suggests a study published yesterday in the New England Journal of Medicine (NEJM).
Those with chronic high blood pressure (BP) saw small but consequential BP increases during COVID-19.
Two new infections an 9 new deaths raise the outbreak total to 130 cases, 43 of them fatal.
Americans who received an mRNA COVID-19 vaccine after SARS-CoV-2 infection are more likely to experience severe systemic adverse events (AEs) than their never-infected counterparts, according to a study published yesterday in Vaccine.
A new study published in eClinicalMedicine analyzed 19 studies on monkeypox, which included 7,553 reported cases, among which there were 555 hospitalizations. The meta-analysis suggests monkeypox patients have a 14.1% hospitalization rate.
The study took place during Mali's malaria season, and findings suggest the treatment is worth pursuing.
Factors that contributed to higher death rates Blacks persisted, but adherence to protective measures widened along political lines, lifting fatalities in Whites.
After the COVID-19 vaccine rollout to adults, Americans living in states with Republican-controlled governments were at an 11% higher risk of COVID-19 death than those in Democrat-led states, and residents of right-leaning states had a 26% higher death rate than those in states with a left-leaning voter majority.
The World Health Organization (WHO) monkeypox emergency committee met for the third time on Oct 20 to discuss the latest developments, concluding that the situation still warrants a public health emergency of international concern (PHEIC).
Officials are now reporting 128 lab-confirmed cases, up from 109, and the case-fatality rate is 28%.
The risk of overall infant neurodevelopment didn't change in the first year of COVID-19.
